Fulcrum Therapeutics
FULC
FULC
55 hedge funds and large institutions have $163M invested in Fulcrum Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
56% less capital invested
Capital invested by funds: $374M → $163M (-$210M)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.91M | |
| 2 | +$9.12M | |
| 3 | +$3.58M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.02M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.66M |
Top Sellers
| 1 | -$20.7M | |
| 2 | -$16.1M | |
| 3 | -$15.8M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.5M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$5.38M |